However, in most studies, copeptin was independently associated with insulin resistance, obesity, and T2DM in adjusted models, which evidences its contribution, as an indirect marker of the AVP regulatory system in metabolic disorders and key components of MetS in different populations. Here, AVP is linked to type 2 diabetes mellitus.